Abstracts of the 17th International Isotope Society (UK group) Symposium Synthesis and Applications of Labelled Compounds 2008

Autor: F. I. Aigbirhio, P. Allen, S. Andersson, M. Anton, D. Barron, A. J. Bloom, N. P. Botting, W. Brandau, L. Brichard, J. A. Brown, R. T. Brown, K. M. Cable, M. Caffrey, M. A. Carroll, D. J. Chaplin, V. Coissard, F. Cuyckens, O. Demmer, I. Dijkgraaf, A. M. Dyke, D. M. Gill, K. A. Hall, A. J. Hester, M. Hickey, S. Irvine, C. Janssen, W. J. Kerr, H. Kessler, L. P. Kingston, C. Landreau, K. W. M. Lawrie, G. Lloyd-Jones, H. Loaring, W. J. S. Lockley, L. J. Marshall, B. Mo, J. D. Moseley, V. L. Murrell, G. N. Nilsson, R. Oekonomopulos, K. G. Pinney, S. Pleasance, S. Raddatz, A. T. Rees, R. G. Reid, J. S. Renny, F. Robert, D. Rustidge, U. Schumacher, D. M. Schwaiger, S. Sharma, D. Soloviev, A. C. Spivey, M. Sriram, J. Thijssen, C.-C. Tseng, W. Verluyten, F. Viton, M. Vliegen, H. Weldon, H-J. Wester, D. J. Wilkinson, J. M. J. Williams, G. Williamson, C. L. Willis, R. Yan

Publikováno v: Journal of Labelled Compounds and Radiopharmaceuticals. 52:208-222

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b4c17c2ff106fc95a564f0549c006dc0
https://doi.org/10.1002/jlcr.1590

Combretastatin A-4 resistance in H460 human lung carcinoma demonstrates distinctive alterations in beta-tubulin isotype expression

Autor: H, Wehbe, C M, Kearney, K G, Pinney

Publikováno v: Anticancer research. 25(6B)

Tubulin isotype distribution may play a role in the development of anti-cancer anti-tubulin drug resistance as well as in drug efficacy and specificity. Stepwise selection was used to establish non-small cell lung carcinoma (NSCLC) H460 cells resista

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9c8fc0857827c6bae1a98b574072611f
https://pubmed.ncbi.nlm.nih.gov/16309172